🕵️ XPO, Inc. ($XPO)
SEC insider & ownership activity, last 12 months · CIK 1166003 · every row links its SEC filing
Over the last 12 months insiders sold $956K with no open-market buying against it. Allison Landry sold $956K in discretionary trades (Sep–May). Blackrock, Inc. added 8.8% → 10.4%; Capital Research Global Investors trimmed 9.5% → 8.2%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $956K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Allison Landry | 0 | – | 2 | $956K | May 28, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 10.4% | 13G | Jun 4, 2026 | filing ↗ | |
| Capital Research Global Investors | 8.2% | 13G | May 14, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 30, 2026 | filing ↗ | |
| Capital World Investors | 5.0% | 13G | May 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Allison Landry | $517K | May 28, 2026 | filing ↗ |
| Allison Landry | $439K | Sep 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 24, 2026 | filing ↗ |
| Other events (8.01) | Jul 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Material agreement (1.01) | May 29, 2026 | filing ↗ |
| New financial obligation (2.03) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 20, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Earnings (2.02) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Earnings (2.02) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Other events (8.01) | Oct 23, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2025 | filing ↗ |